PPU counsels IDB Invest on Farmalatam investment
Philippi Prietocarrizosa Ferrero DU & Uría has assisted the pharmaceutical on the transnational transaction
PPU Colombia and PPU Peru advised IDB Invest on its investment in the Panamanian company Farmalatam Holding Inc for S$8 million. Farmalatam Holding Inc is the holding company of the Farmalisto Group which participates in the healthcare markets in Colombia, Mexico and Peru through subsidiaries incorporated in those jurisdictions. Additionally, the investment made by IDB Invest was part of a capitalization round for an aggregate value of $18 million, in which HBM Healthcare Investments (main shareholder of Farmalisto) and the private equity fund Morgan Rio also participated.
This transaction involved a complex cross-border analysis of several significant legal matters in Colombia, Mexico and Peru. Remarkably, the healthcare sector has become the focus of policymakers due to the Covid-19 pandemic. As a result of this, the transaction’s structuring required a thorough analysis of the regulatory framework applicable to Farmalisto.
Philippi Prietocarrizosa Ferrero DU & Uría as Colombian and Peruvian counsel to IDB Invest with a team led by Colombian partner Hernando Padilla (pictured left) and Peruvian Rafael Boisset (pictured right), and involved associates Alejandro Medina, Noelia Martiátegui, Pedro Arango, and Ximena González.
Becker Glynn as New York Counsel to IDB Invest with a team formed by partner Patrick O’Brien and associate Andrés Sardi.
Creel, García-Cuellar as Mexican counsel to IDB Invest with a team formed by associates Gerardo Zimbrón and Paola Carrasco.
Alfaro, Ferrer y Ramírez as Panamanian counsel to IDB Invest with partner Roberto Harrington.
Brick Abogados as Colombian counsel to Farmalisto with a team formed by associates Vanesa González and Andrés Rodríguez.
